prednisolone has been researched along with Delayed Effects, Prenatal Exposure in 12 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this retrospective case series, we found no evidence of prolonged effects of maternal prednisolone use during pregnancy on the neonatal hypothalamic-pituitary-adrenal axis." | 3.85 | Maternal use of prednisolone is unlikely to be associated with neonatal adrenal suppression-a single-center study of 16 cases. ( Bocca, G; de Vetten, L; Kema, IP; van Stuijvenberg, M, 2017) |
| "Prednisolone is widely used to treat medical conditions in pregnancy, despite the lack of long-term safety studies on infants." | 3.72 | Infant cortisol response after prolonged antenatal prednisolone treatment. ( Fisk, NM; Glover, V; Miller, NM; Williamson, C, 2004) |
| "The influence of prenatal exposure to the synthetic glucocorticoid prednisolone (PRED) was examined in female offspring of mice administered the drug on Days 13-18 of pregnancy." | 3.66 | Deleterious effects of prenatal prednisolone exposure upon morphological and behavioral development of mice. ( Gandelman, R; Rosenthal, C, 1981) |
| "83 prednisolone-treated and 57 control children of a previous study demonstrating benefits of antenatal steroid prophylaxis of IRDS were reexamined at the age of 6 years." | 1.27 | Normal physical and mental development of 6-year-old children whose mothers were treated antenatally with prednisolone. ( Adamovich, K; Arató, J; Horváth, I; Ostorharics-Horváth, G; Papp, K, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kieffer, TE | 1 |
| Chin, PY | 1 |
| Green, ES | 1 |
| Moldenhauer, LM | 1 |
| Prins, JR | 1 |
| Robertson, SA | 1 |
| de Vetten, L | 1 |
| van Stuijvenberg, M | 1 |
| Kema, IP | 1 |
| Bocca, G | 1 |
| Shimizu, M | 1 |
| Sakakibara, Y | 1 |
| Kawano, M | 1 |
| Yachie, A | 1 |
| Miller, NM | 1 |
| Williamson, C | 1 |
| Fisk, NM | 1 |
| Glover, V | 1 |
| Ducray, F | 1 |
| Colin, P | 1 |
| Cartalat-Carel, S | 1 |
| Pelissou-Guyotat, I | 1 |
| Mahla, K | 1 |
| Audra, P | 1 |
| Gaucherand, P | 1 |
| Honnorat, J | 1 |
| Trouillas, P | 1 |
| Horváth, I | 2 |
| Adamovich, K | 2 |
| Arató, J | 2 |
| Ostorharics-Horváth, G | 2 |
| Papp, K | 2 |
| Gandelman, R | 1 |
| Rosenthal, C | 1 |
| Rink, T | 1 |
| Wieg, C | 1 |
| Schroth, HJ | 1 |
| Helisch, A | 1 |
| Bertram, U | 1 |
| Taniguchi, H | 2 |
| Yoshitomi, H | 1 |
| Miyazaki, K | 1 |
| Koga, N | 1 |
| Himeno, Y | 2 |
| Hara, Y | 1 |
| Nakamura, M | 2 |
| Tsuji, M | 2 |
| Tanaka, H | 3 |
| Shinomiya, M | 3 |
| Chono, M | 1 |
| Araki, E | 1 |
| Aso, S | 1 |
| Morita, S | 1 |
| Kajiwara, Y | 1 |
| Horiwaki, S | 1 |
12 other studies available for prednisolone and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Prednisolone in early pregnancy inhibits regulatory T cell generation and alters fetal and placental development in mice.
Topics: Animals; Cell Differentiation; Female; Fetal Development; Fetus; Gestational Age; Lymphopoiesis; Mal | 2020 |
Maternal use of prednisolone is unlikely to be associated with neonatal adrenal suppression-a single-center study of 16 cases.
Topics: Adrenal Insufficiency; Female; Follow-Up Studies; Glucocorticoids; Humans; Hypoglycemia; Hypothalamo | 2017 |
Transient impairment of NK cell function in an infant born to a mother with adult-onset Still's disease: perinatal effect of maternal IL-18.
Topics: Adult; Cyclosporine; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infant, | 2012 |
Infant cortisol response after prolonged antenatal prednisolone treatment.
Topics: Adult; Cohort Studies; Crying; Female; Humans; Hydrocortisone; Infant; Mother-Child Relations; Predn | 2004 |
[Management of malignant gliomas diagnosed during pregnancy].
Topics: Abortion, Therapeutic; Adrenal Cortex Hormones; Adult; Algorithms; Anesthesia, General; Antineoplast | 2006 |
[Follow-up studies on 6-year-old children of mothers having previously undergone preventive steroid therapy].
Topics: Abnormalities, Drug-Induced; Child; Developmental Disabilities; Female; Follow-Up Studies; Humans; M | 1984 |
Normal physical and mental development of 6-year-old children whose mothers were treated antenatally with prednisolone.
Topics: Child; Child Development; Female; Humans; Infant, Newborn; Intelligence; Male; Mental Processes; Pre | 1984 |
Deleterious effects of prenatal prednisolone exposure upon morphological and behavioral development of mice.
Topics: Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Ethamox | 1981 |
[Hyperthyroidism in a premature infant due to transplacental passage of maternal thyrotropin receptor antibodies].
Topics: Adult; Anti-Arrhythmia Agents; Antithyroid Agents; Autoantibodies; Carbimazole; Cardiotonic Agents; | 1999 |
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--study by subcutaneous administration of PNF prior to and in the early stages of pregnancy in rats].
Topics: Animals; Body Weight; Embryonic and Fetal Development; Farnesol; Female; Fetus; Injections, Subcutan | 1992 |
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--study by subcutaneous administration of PNF during the period of fetal organogenesis in rats].
Topics: Animals; Behavior, Animal; Body Weight; Embryonic and Fetal Development; Farnesol; Female; Fetus; In | 1992 |
[Reproductive and developmental toxicity study of prednisolone farnesylate (PNF)--teratogenicity study in rabbits by subcutaneous administration].
Topics: Animals; Body Weight; Embryonic and Fetal Development; Farnesol; Female; Fetus; Injections, Subcutan | 1992 |